Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
Clinical trial NCT00209989 · COMPLETED
Trial details
- NCT number
- NCT00209989
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2011-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.